risk factors such as low income, low education, minority race/ethnicity, and single living were associated with lower levels of Life's Simple 7 scores after adjusting for age and sex. 15 Because a positive family history of premature heart disease is a known risk factor for heart disease, it is important to characterize its public health impact in terms of population prevalence of family history of heart disease, the burden of heart disease attributable to family history, and whether family history interacts with modifiable risk factors for heart disease. To the best of our knowledge, such analyses have not been done in a representative sample of the US population. NHANES (the National Health and Nutrition Examination Survey) provides a unique opportunity to conduct such an analysis, as the survey is population based, representative, and weighted and collects information on heart disease, heart disease risk factors, and family history of premature heart disease (FHPHD, under age 50).
Materials and Methods
All data and materials used in this study are publicly available at the National Center for Health Statistics website. 16 
NHANES
NHANES is a series of cross-sectional surveys using stratified, multistage probability samples designed to provide assessments on the health and nutrition status of the civilian, noninstitutionalized US population. NHANES is conducted by the Centers for Disease Control and Prevention's National Center for Health Statistics and has continuously collected data based on personal interviews and physical examination of survey participants in 2-year cycles since 1999. The present study included samples of adults aged ≥20 years in the cycles 2007 to 2014. Detailed methods of the NHANES survey construction and sampling strategy are available elsewhere (https://www.cdc.gov/nc hs/data/series/sr_02/sr02_162.pdf). Participants complete an in-home interview for basic demographic and health information along with a scheduled visit to a mobile examination center for physical examination and laboratory testing. Informed consent was obtained from all participants for both parts of the survey, and the National Center for Health Statistics ethics review board approved all the protocols. Pregnant women were excluded because of the effect of pregnancy on glucose measurement.
Family History of Premature Heart Disease
If a participant reported that they had ever been diagnosed with coronary heart disease, angina, heart attack, or stroke by a doctor or other health professional, we defined that person as having CVD. Participants were asked whether any of their close biological (blood) relatives, including father, mother, sisters, or brothers, were ever told by a health professional that they had a heart attack or angina before the age of 50. We defined participants as having a reported family history of premature heart disease (FHPHD) if they responded "yes" to this question. Further information on family history of CVD is not available in NHANES 2009-2014 to do a more comprehensive analysis.
Statistical Analysis
We used a logistic regression model to measure the association between CVD and self-reported FHPHD. We included other risk factors in the model: age group (20-39, 40-59, ≥60 years), sex, race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, others [non-Hispanic]), body mass index (BMI) (<25, 25-29.9, ≥30 kg/m 2 ), current smoker (yes/no), and leisure time physical activity (yes/no). We did not consider other racial/ethnic groups because sample sizes were too small for meaningful analysis. We defined participants as physically active if the participant had ≥150 min/ week moderate intensity activity or ≥75 min/week vigorous
Clinical Perspective
What Is New?
• Using a representative sample of the US population, this study showed that family history of premature heart disease is common in the United States (estimated 27.8 million people over 20 years of age), and millions of people who are at increased risk for cardiovascular disease can be identified using family history.
• Among young people (20-39 years of age) with cardiovascular disease, about 1 in 3 could be attributed to the family history of premature heart disease (burden of 0.3 million young people).
• Among people without prevalent cardiovascular disease, people with family history of heart disease have a much less favorable heart health rating compared with people without a family history, including several modifiable risk factors (such as physical activity and cholesterol).
What Are the Clinical Implications?
• Awareness of family history of premature heart disease and associated modifiable risk factors is important for clinicians to make appropriate diagnosis, start early treatment, and promote healthy lifestyles in their patients, and for the public to collect, understand, and act on their family history to reduce their risk of premature heart disease.
intensity activity or 29min/week vigorous intensity activity+min/week moderate intensity activity ≥150. We also included income-to-poverty ratio (<1/≥1) and education (less than high school completion/high school completion or greater) in the model as indicators of socioeconomic status. Income-to-poverty ratio is the ratio of family income to poverty guidelines. We also tested for significant interactions between family history and other risk factors by including 1 interaction term at a time in the model. We estimated the population attributable fraction (PAF) for FHPHD using the formula, PAF ¼ GðRÀ1Þ
GðRÀ1Þþ1 , where G is the prevalence of FHPHD in the population and R is the prevalence ratio. When the prevalence of CVD was <10% for a given population, we used OR as an approximate estimate for prevalence ratio. 17 When the prevalence of CVD was relatively large (>10%), the approximate estimate of prevalence ratio was obtained from ORs, using the formula, prevalence ratio ¼ OR
, where p 0 is the prevalence of CVD in the population who do not have a FHPHD. 17 Next,
we calculated the number of cases impacted by FHPHD in the population by multiplying PAF and the number of cases with CVD. To calculate the total number of cases with CVD by age group, we used the distribution of the civilian noninstitutionalized US population obtained from the Census Bureau's Current Population Survey as recommended by the National Center for Health Statistics. 18 We multiplied the average population size for the 4 survey cycles by the prevalence of CVD. After excluding participants with missing data for the variables used in the logistic regression, the study sample consisted of 19 253 nonpregnant adult respondents aged ≥20 that included 1787 CVD cases and 2304 participants with FHPHD.
Cardiovascular health metrics
Next, we compared the cardiovascular health metrics between participants with and without FHPHD for those who had not yet developed CVD. Cardiovascular health metrics included BMI, smoking, physical activity, healthy dietary scores, total cholesterol, blood pressure, and fasting plasma glucose. The definitions of ideal, intermediate, and poor cardiovascular health metrics for adults were given in Table 3 of Lloyd-Jones et al 9 .
Instead of using their dietary criteria, we used Healthy Eating Index-2010 (HEI-2010) scores, which were calculated from dietary information collected by a single 24-hour dietary recall. 19 The Healthy Eating Index-2010 is a measure of diet quality that tracks the federal dietary guidelines for Americans. It has 12 components: total fruit, whole fruit, total vegetables, greens and beans, whole grains, dairy, total protein foods, seafood and plant protein, fatty acid, refined grains, sodium, and empty calories. 19 The total scores range from 0 to 100, with higher scores indicating a healthier diet. A score of 0, 1, or 2 was assigned to each cardiovascular health metric to represent poor, intermediate, or ideal health, respectively. Based on the sum of scores for all 7 cardiovascular metrics, an overall score, ranging from 0 to 14, was categorized as inadequate (0-4), average (5-9), or optimum (10-14) cardiovascular health. 21, 22 We compared characteristics of participants with an FHPHD with those without a family history using t tests. We used polytomous logistic regression to estimate the adjusted prevalence ratios (PRs) of FHPHD comparing average or inadequate cardiovascular health with optimum cardiovascular health, adjusted for age, sex, race/ethnicity, education, and income-to-poverty ratio. For this analysis, we excluded participants with missing cardiovascular health metric scores, missing values of covariates, and FHPHD. We also excluded participants with a history of CVD and participants with BMI <18.5. The sample for this analysis consisted of 16 431 nonpregnant adult respondents aged ≥20 years that included 1863 participants with a family history of CVD. The family history question in NHANES asked only about heart attack or angina, whereas the CVD definition also included stroke or coronary heart disease. We conducted a sensitivity analysis to examine the consistency of results obtained for the association of FHPHD with CVD and cardiovascular health metrics by changing the outcome variable to heart attack or angina instead of CVD.
Heart Age Calculation
Finally, we compared the predicted mean heart age for participants aged 30 to 74 years with an FHPHD with those without a family history. Based on the Framingham study participants, D'Agostino et al 23 presented simple sex-specific risk functions to evaluate the 10-year risk of developing overall CVD. The nonlaboratory predictors for the multivariable risk factor algorithm included age, BMI, treated and untreated systolic blood pressure, smoking, and diabetes mellitus. They also introduced heart age, the estimated age of a person's vascular system based on these predictors. The difference between heart age and chronological age provides an effective way to communicate risk for developing CVD. 24 We age-adjusted heart age and excess heart age (defined as the difference between heart age and chronological age) using the age groups 30 to 39, 40 to 49, 50 to 59, and 60 to 74 years and the 2000 US standard population. The survey data were analyzed using SURVEYFREQ and SURVEYLOGISTIC procedures in SAS version 9.3 (SAS Institute, Cary, NC) that takes into account the complex survey design of the NHANES, and the sample weights were adjusted for pooling 4 cycles of NHANES data. Table 1 gives the prevalence of reported FHPHD and the estimated population with FHPHD for the US population by age group, sex, race/ethnicity, education, income-to-poverty ratio, and BMI. The prevalence of FHPHD in the US population aged ≥20 years was 12.55% (95% CI, 11.81-13.29). Based on the average US population during 2007 to 2014, around 27.8 million people aged ≥20 had an FHPHD. The prevalence of reported FHPHD was significantly higher among age groups 40 to 59 (14.21%; 95% CI, 12.80-15.62) and ≥60 (15.09; 95% CI, 13.43-16.75) compared with the age group 20 to 39 (9.02%; 95% CI, 8.23-9.81). By race/ethnicity groups, the non-Hispanic white population had the highest prevalence of FHPHD, an estimate of 13.82% (95% CI, 12.76-14.87). The prevalences of FHPHD for non-Hispanic black and Hispanic populations were 11.17% (95% CI, 9.97-12.37) and 8.91% (95% CI, 8.11-9.71), respectively. Females had a higher prevalence of FHPHD (14.03%; 95% CI, 13.05-15.0) compared with males (10.98 95% CI, 10.07-11.90). Populations with BMI ≥30, less than high school education, and income-to-poverty ratio <1 had significantly higher prevalence of FHPHD than those with BMI <30, more education, and income-topoverty ratio ≥1, respectively.
Results
During 2007 to 2014, the crude prevalence of CVD in the US population ≥20 years was 7.44% (95% CI, 6.95, 7.94). The prevalence of CVD for the population with a FHPHD (15.72%; 95% CI, 13.81-17.64) was more than double the prevalence of CVD for those without a family history (6.25%; 95% CI, 5.82-6.69). Table 2 presents the prevalence of CVD among those with and without an FHPHD for the populations with risk factors related to CVD, and Table 3 describes the adjusted odds ratios (aORs) of these risk factors associated with CVD in the logistic regression model. The prevalence of CVD for those with an FHPHD was more than double the prevalence of CVD for those without an FHPHD in all categories of these risk factors except people aged ≥60 years and people with BMI 25 to 29.9. All the interaction terms of risk factors with family history were nonsignificant except for age in the logistic regression model. Because the interaction of FHPHD and age was significant (P<0.001), we present the aOR of family history for each age group in Table 3 . The aOR of FHPHD for age 20 to 39 was 5.91 (95% CI, 3.34-10.44); for age 40 to 59 was 3.02 (95% CI, 2.41-3.79); and for age ≥60 was 1.87 (95% CI, 1.54-2.28). During 2007 to 2014, the average US population for the age groups 20 to 39, 40 to 59, and ≥60 were 81.5, 84.2, and 56.1 million, respectively. Using the prevalence estimates of CVD for these age groups (1.05%, 5.32%, and 19.66%, respectively), we estimated that 0.9, 4.5, and 11.0 million people had CVD in the age groups 20 to 39, 40 to 59, and ≥60, respectively. Since the PAFs for reported FHPHD for these 3 age groups were 30.68%, 22.30%, and 8.58%, respectively, %0.3, 1.0, and 1.0 million cases with CVD could be attributed to having an FHPHD. The aOR for males was 75% higher (95% CI, 1.49-2.06) than that of females. The odds of having CVD was 24% lower for Hispanics (95% CI, 0.63-0.91), compared with that of nonHispanic whites. The aOR for the association between BMI ≥30 and prevalence of CVD was 1.55 (95% CI, 1.34-1.80) compared with that of BMI <25. The aORs for current smokers, those who were not physically active, had less than high school education, and income-to-poverty ratio <1 ranged from 1.36 to 1.66. Table 4 presents a comparison of the distributions of the populations free of CVD distributed in categories: ideal, intermediate, and poor health, between those with and without an FHPHD for each "Life's Simple 7" cardiovascular metric. The percentages of the population with an FHPHD in ideal health were significantly less than that for the population without a family history for BMI risk (26.7 versus 30.7), smoking risk (71.0 Tables 3 and 4 when the outcome is heart attack or angina instead of CVD are presented in Table S1 and S2, respectively. The pattern of associations and the difference in distributions of the cardiovascular health metrics were largely consistent for both outcomes. Table 6 presents the predicted age-adjusted mean heart age and the predicted age adjusted mean excess heart age for the overall population aged between 30 and 74 as well as for those with and without an FHPHD. The estimated heart age for those with an FHPHD was significantly higher (57.6 versus 55.0) compared with those without a family history. Similarly, the excess heart age (heart age-chronological age), for those with an FHPHD was significantly higher (9.6 versus 7.0) compared with those without a family history, indicating that, on average, US adults aged 30 to 74 with an FHPHD have a heart age that is 9.6 years older than their actual age.
Discussion
Our findings confirm the public health importance of family history as a risk factor associated with CVD. Using a populationbased representative survey, we show that reported FHPHD is common in the United States (12.5%, or 27.8 million people over age 20). These data suggest that millions of people who are people). The PAF for parental history of MI (14.8%) for younger individuals (men ≤55 years and women ≤60 years) was also significantly higher in the INTERHEART study. 25 Family history was not included in any version of the Framingham risk score to estimate CVD risk, and only a few risk calculators include family history of CVD to assess a patient's risk. 25, 26 However, both parental and sibling history were found to improve prediction of CVD. 27, 28 The joint 2013
American College of Cardiology/American Heart Association Taskforce guideline for the assessment of cardiovascular risk recommends for FHPHD to be considered if, after quantitative risk assessment, a risk-based treatment is uncertain. The Work Group supported revising risk assessment upward for males <55 and females <65 years of age with FHPHD. 29 As risk from family history depends on number of first-degree relatives affected, type of relatives, and the age of onset of CVD, it has been shown that using more sophisticated definitions of family history variables compared with a simple binary approach significantly improved the predictive ability of coronary heart disease risk models. 30 The prevalence of CVD in people with an FHPHD is more than double the prevalence of CVD among people without a family history. Among people without prevalent CVD, our findings show that people with an FHPHD have a much less favorable heart health rating compared with people without a family history. Either the percentages of the population with an FHPHD in ideal health were significantly less than that for the population without a family history, or the percentages of the population with a FHPHD in poor health were significantly higher than that for the population without a family history for the 7 cardiovascular metrics considered. After controlling for other variables, the PR for FHPHD was almost double for inadequate health relative to optimal health. Our findings also show that both heart age and excess heart age were significantly higher among those who have an FHPHD compared with those without a family history. Another study of association between family history of diabetes mellitus and FHPHD and lifestyle risk factors in the US population based on NHANES 2009-2012 found that participants with an FHPHD were more likely to be current smokers and participants with a family history of both diabetes mellitus and CVD were more likely to have obesity compared with participants with no family history. 31 There was no association between family history and dietary factors or physical activity. However, their study sample did not exclude those who had already developed CVD.
The findings that people with FHPHD are in worse heart health than those without FHPHD may be unexpected to some since the 7 cardiovascular metrics considered in our study are based on modifiable risk factors, and lifestyle modifications can reduce the risk of developing CVD. It is reasonable to expect that knowing their family history, people with FHPHD could be more motivated to make positive lifestyle and behavior changes than those without a family history or may have a more fatalistic approach to their own heart health. These data have important implications for targeting public heath, clinical, and public health education program interventions to this high-risk group. Better strategies to collect comprehensive family history of CVD may improve the effectiveness of family history as a tool for preventing CVD. 32 
Study Limitations
There are several limitations in our study. NHANES is a crosssectional survey, and cannot be used to show causal effect of the FHPHD on CVD. The risk of FHPHD on CVD is well known in the literature, and thus in calculating numbers attributed to FHPHD, we assumed the causality of FHPHD on CVD. Moreover, the collection of family health history information is limited in the NHANES. There have been no populationbased surveys that examined the accuracy of self-reported family histories of CVD. However, other studies that investigated the accuracy of family history of CVD found that offspring report of parental history may be unreliable and may lead to overestimates of risk associated with parental CVD. 27, 33, 34 The differences in prevalence of reported family history between men and women also suggest that there may be a recall or knowledge bias. 35 The accuracy of self-reports of the medical history varies on the participants' knowledge of the pertinent information, ability to recall it, and inclination to report it. 36 A study conducted on patients with hypercholesterolemia enrolled in primary care centers in Germany to obtain more information on the accuracy of patient-provided data, on cardiovascular conditions compared with medical records showed excellent and substantial agreement for patient self-report and medical record regarding diabetes mellitus and hypertension but showed only moderate agreement for both MI and stroke. 37 Misreporting of medical history including FHPHD and history of CVD could introduce bias in the association study. As the participants were asked whether any of their close biological (blood) relatives, including sisters or brothers, were ever told by a health professional that they had a heart attack or angina before the age of 50, the family history question did not distinguish between full and half siblings. Therefore, our results may also include second-degree relatives in addition to the first degree relatives. The inclusion of half siblings may dilute the impact of family history on CVD. Furthermore, the age cutoff point for the definition of premature heart disease is higher than 50 years in some studies of CVD. For example, Lloyd-Jones et al 27 defined premature parental CVD as the occurrence of a validated parental event before age 55 years in a father or age 65 years in a mother. These were also the cut points recommended by the National Cholesterol Education Program Third Adult Treatment Panel 38 and Seventh Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 39 A lower cut point for age for the definition of premature heart disease may increase the impact of FHPHD on CVD.
Because the definition of FHPHD is based only on heart attack or stroke, we examined the possible effect of this definition on CVD outcomes, and the patterns of associations were largely consistent for the consistent definition of FHPHD and CVD outcomes. As Healthy Eating Index-2010 was from the first-day 24-hour dietary recall, the energy intake may be underestimated by as much as 11%. 40 Another limitation in our study is the absence of specific data on genetic factors, including polygenic risk scores 41 and major genetic conditions such as familial hypercholesterolemia. However, with an estimated prevalence of 1 in 250 people, familial hypercholesterolemia accounts for a small proportion of people with an FHPHD. 42 In conclusion, millions of people who are at high risk of having or developing CVD could be identified using FHPHD. In addition, FHPHD is associated with increased prevalence of modifiable risk factors for CVD. FHPHD can become be an important component of public health campaigns that plan to reduce the overall risk of heart disease by working on modifiable risk factors. Each year since 2004, the Surgeon General has declared Thanksgiving to be National Family History Day and encourages Americans to use his "My Family Health Portrait," which is an Internet-based tool that makes it easy to record family health history. 43 Further work is needed to assess how this knowledge can be used in public health programs such as the "Million Hearts" initiative that are targeting the reduction of heart disease in the US population. 44 
